malondialdehyde has been researched along with Bladder Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albayrak, S; Atar, M; Gurdal, M; Gurel, A; Imamoglu, MA; Sahin, S; Tanik, S; Tuzcu, M; Tuzcu, N; Zengin, K | 1 |
| Dimitriadis, F; Kinoshita, Y; Martin, DT; Ohmasa, F; Oikawa, R; Oiwa, H; Saito, M; Satoh, I; Shimizu, S; Tomita, S; Tsounapi, P | 1 |
| Kazuyama, E; Kinoshita, Y; Saito, M; Satoh, I; Satoh, K; Shimizu, S; Tamamura, M | 1 |
| Aksungar, FB; Ekici, S; Midi, A; Sinanoglu, O; Yener, AN | 1 |
| Gong, DX; Jiang, YJ; Kong, CZ; Liu, HB; Sun, ZX; Yang, CM | 1 |
| Horan, P; Levin, RM; Liu, SP; Ohnishi, N | 1 |
6 other study(ies) available for malondialdehyde and Bladder Diseases
| Article | Year |
|---|---|
Assessment of therapeutic effect of human choriogonadotropin in a chemical cystitis model.
Topics: Animals; Chorionic Gonadotropin; Cystitis; Disease Models, Animal; Female; Glutathione; Humans; Interferon-gamma; Malondialdehyde; Rats; Tumor Necrosis Factor-alpha; Urinary Bladder Diseases | 2017 |
Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress.
Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Disease Models, Animal; Hypertension; Imidazoles; Male; Malondialdehyde; Nerve Growth Factor; NF-E2-Related Factor 2; Nifedipine; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Wistar; Regional Blood Flow; Tetrazoles; Urinary Bladder; Urinary Bladder Diseases; Urodynamics | 2014 |
Acute urinary retention and subsequent catheterization cause lipid peroxidation and oxidative DNA damage in the bladder: preventive effect of edaravone, a free-radical scavenger.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acute Disease; Animals; Antipyrine; Deoxyguanosine; DNA Damage; Edaravone; Free Radical Scavengers; HSP70 Heat-Shock Proteins; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Urinary Bladder Diseases; Urinary Catheterization; Urinary Retention | 2009 |
The protective effects of spirulina in cyclophosphamide induced nephrotoxicity and urotoxicity in rats.
Topics: Animals; Antioxidants; Catalase; Cyclophosphamide; Cystitis; Immunohistochemistry; Immunosuppressive Agents; In Situ Nick-End Labeling; Kidney; Kidney Diseases; Lipid Peroxidation; Malondialdehyde; Oxidative Stress; Rats; Spirulina; Superoxide Dismutase; Urinary Bladder; Urinary Bladder Diseases | 2012 |
Ability of alpha-lipoic acid to reverse the diabetic cystopathy in a rat model.
Topics: Animals; Antioxidants; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Male; Malondialdehyde; Nerve Growth Factor; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thioctic Acid; Urinary Bladder; Urinary Bladder Diseases | 2008 |
Effect of repetitive stimulation on the contractile response of rabbit urinary bladder subjected to in vitro hypoxia or in vitro ischemia followed by reoxygenation.
Topics: Animals; Carbachol; Cell Hypoxia; Disease Models, Animal; Electric Stimulation; Glucose; In Vitro Techniques; Ischemia; Lipid Peroxidation; Male; Malondialdehyde; Muscle Contraction; Nitrogen; Oxygen; Potassium Chloride; Rabbits; Reflex, Abnormal; Reperfusion; Time Factors; Urinary Bladder; Urinary Bladder Diseases | 1998 |